Biomedical Engineering Reference
In-Depth Information
Kyle MK (2006) The role of firm characteristics in pharmaceutical product launches. Rand J Econ
73(3):602-618
Kyle MK (2007) Pharmaceutical price controls and entry strategies. Rev Econ Stat 89(1):88-99
Landsman V, Givon M (2010) The diffusion of a new service: combining service consideration and
brand choice. Quant Mark Econ 8(1):91-121
Lanjouw JO (2005) Patents, price controls and access to new drugs: how policy affects global
market entry. NBER working paper 11321. NBER, Cambridge, MA
Lee TH (2004) Me-too products—friend or foe? N Engl J Med 350:211-212
Lee JYC, Lee, JD, Lee CY (2006) Forecasting future demand for large-screen television sets using
conjoint analysis with diffusion model. Technological Forecasting and Social Change,
73(4):362-376
Leeflang P, Wieringa J, Wittink D (2004) The effects of pharmaceutical marketing on sales of
prescription drugs in the Netherlands. In: Sixth CU-Boulder invitational choice symposium,
Estes Park, CO
Lehmann D, Esteben-Bravo M (2006) When giving some away makes sense to jump-start the dif-
fusion process. Mark Lett 17(4):243-254
Lewis LK, Seibold DR (1993) Innovation modification during intraorganizational adoption. Acad
Manage Rev 18(2):322-354
Lexchin J (2004) The effect of generic competition on the price of brand-name drugs. Health
Policy 68:47-54
Libai B, Muller E, Peres R (2005) The role of seeding in multi-market entry. Int J Res Mark
22(4):375-393
Lilien G, Rao A, Kalish S (1981) Bayesian estimation and control of detailing effort in a repeat
purchase diffusion environment. Manag Sci 27(5):493-506
Ling DC, Berndt ER, Kyle MK (2002) Deregulating direct-to-consumer marketing of prescription
drugs: effects on prescription and over-the-counter product sales. J Law Econ 45(2):691-723
Lu ZJ, Comanor WS (1998) Strategic pricing of new pharmaceuticals. Rev Econ Stat 80(1):
108-118
Mahajan V, Muller E (1994) Innovation diffusion in a borderless global market: will the 1992
unification of the European Community accelerate diffusion of new ideas, products, and tech-
nologies? Technol Forecast Soc Change 45(3):221-235
Mahajan V, Muller E (1996) Timing, diffusion, and substitution of successive generations of
technological innovations: the IBM mainframe case. Technol Forecast Soc Change 51(2):
109-132
Mahajan V, Muller E, Kerin RA (1984) Introduction strategy for new products with positive and
negative word-of-mouth. Manag Sci 30(12):1389-1404
Manchanda P, Chintagunta PK (2004) Responsiveness of physician prescription behavior to sales
force effort: an individual level analysis. Mark Lett 15(2-3):129-145
Manchanda P, Rossi PE, Chintagunta PK (2005) Response modeling with nonrandom marketing-
mix variables. J Mark Res 41(4):467-478
Manchanda P, Xie Y, Youn N (2008) The role of targeted communication and contagion in product
adoption. Mark Sci 27(6):961-976
Mesak H, Darrat A (2002) Optimal pricing of new subscriber services under interdependent adop-
tion processes. J Serv Res 5(2):140-153
Meyerhoefer CD, Zuvekas SH (2008) The shape of demand: what does it tell us about direct-to-
consumer marketing of antidepressants? B E J Econ Anal Policy 8(2 Advances):article 4
Mizik N, Jacobson R (2004) Are physicians easy marks?: quantifying the effects of detailing and
sampling on new prescriptions. Manag Sci 50(12):1704-1715
Moore GA (1992) Crossing the chasm. Harper Business, New York
Morelli D, Koenigsberg MR (1992) Sample medication dispensing in a residency practice. J Fam
Pract 34(1):42-48
Morton FMS (1999) Entry decisions in the generic pharmaceutical industry. Rand J Econ
30(3):421-440
Search WWH ::
Custom Search